Article Details

Malvern-based PhaseBio Secures $34 Million in Series D Financing

Retrieved on: 2018-09-06 03:52:30

Tags for this article:

Click the tags to see associated articles and topics

Malvern-based PhaseBio Secures $34 Million in Series D Financing. View article details on hiswai:

Excerpt

<div>Existing investors <b>New Enterprise Associates</b>, Hatteras Venture Partners, AstraZeneca (NYSE: AZN), Johnson & Johnson Innovation – JJDC, Inc., ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up